Triple-negative breast cancer is a sub-type of breast cancer defined by the lack of expression of the three principal biomarkers associated with breast cancer: oestrogen receptor-α, progesterone receptor and human epidermal growth factor receptor 2 (HER2) [197]. This evidence concerns the gene ERBB2 and breast cancer.